Skip to content
2000
Volume 17, Issue 3
  • ISSN: 2949-6810
  • E-ISSN: 2949-6829

Abstract

Purpose

The study aimed to develop and optimize a sustained-release matrix tablet of diclofenac sodium (50 mg) using carboxymethylated chitosan (CMCS) as the matrix-forming polymer, in combination with hydroxypropyl methylcellulose (HPMC). The research investigated the impact of CMCS (50-200 mg) and HPMC (150-300 mg) composition on the critical quality attributes of the sustained-release matrix tablets.

Methods

A 2-factor mixture design investigated the impact of HPMC and CMCS proportions on critical quality attributes. Tablets (650 mg) were prepared by wet granulation and characterized for flow properties, hardness, and drug release kinetics. The drug release studies were carried out at 37 ± 0.5°C in a phosphate buffer of pH 6.8 using a USP type II dissolution apparatus operated at 50 rpm. The dissolution profile of the optimized formulation was compared with a marketed product, Reactin® SR, using ANOVA and model-independent methods (f1 and f2 values).

Results

Granule properties showed good flow characteristics with Carr's index (14.25-18.36) and Hausner ratio (1.05-1.25). FTIR and DSC studies confirmed no drug-excipient interactions, with the drug's characteristic peaks maintained at 766 cm−1, 1454 cm−1, 1017 cm−1, and 2915 cm−1, and a melting endotherm at 54°C. The optimized formulation (F3) with 150 mg HPMC and 200 mg CMCS demonstrated 90.57% drug release in 8 hours following super case II transport (n = 1.11). The release kinetics best fitted the Korsmeyer-Peppas with the F0 model (R2 = 0.9959). The response parameters hardness (4.2 ± 0.126 kg/cm2), t (115 ± 11.60 min), t (290 ± 21.42 min), and t (630 ± 31.51 min) were best fitted to the quartic model. The similarity factor (f2 = 67.63) and difference factor (f1 = 13.85) indicated the equivalency of the dissolution profile with that of the marketed formulation.

Conclusion

The study successfully developed a sustained-release matrix tablet of diclofenac sodium using CMCS as the primary matrix material. The optimized formulation demonstrated a dissolution profile comparable to the marketed product (>90% release in 8 hours), with f2 > 50 and f1 < 15, suggesting its potential as a generically equivalent alternative. Moreover, the findings indicate that CMCS is an effective carrier for sustained-release formulations and can potentially be applied to other drugs requiring controlled release.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/dmbl/10.2174/0118723128351869250213102431
2025-03-13
2025-08-18

  • From This Site

    /content/journals/dmbl/10.2174/0118723128351869250213102431
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. LinQ. FuY. LiJ. QuM. DengL. GongT. ZhangZ. A (polyvinyl caprolactam-polyvinyl acetate–polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.Eur. J. Pharm. Sci.201579445210.1016/j.ejps.2015.08.018 26349052
     [Google Scholar]
  2. TimminsP. DesaiD. ChenW. WrayP. BrownJ. HanleyS. Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets.Ther. Deliv.20167855357210.4155/tde‑2016‑0026 27444495
     [Google Scholar]
  3. MondalN. The role of matrix tablet in drug delivery system.Int J Appl Pharm20181011610.22159//ijap.2018v10i1.21935
     [Google Scholar]
  4. RenG. ClancyC. TamerT.M. SchallerB. WalkerG.M. CollinsM.N. Cinnamyl O-amine functionalized chitosan as a new excipient in direct compressed tablets with improved drug delivery.Int. J. Biol. Macromol.201914193694610.1016/j.ijbiomac.2019.08.265 31487516
     [Google Scholar]
  5. DesaiN. RanaD. SalaveS. GuptaR. PatelP. KarunakaranB. SharmaA. GiriJ. BenivalD. KommineniN. Chitosan: A potential biopolymer in drug delivery and biomedical applications.Pharmaceutics2023154131310.3390/pharmaceutics15041313 37111795
     [Google Scholar]
  6. OrtizJ.A. SepúlvedaF.A. Panadero-MedianeroC. MurgasP. AhumadaM. PalzaH. MatsuhiroB. ZapataP.A. Cytocompatible drug delivery hydrogels based on carboxymethylagarose/chitosan pH-responsive polyelectrolyte complexes.Int. J. Biol. Macromol.20221999610710.1016/j.ijbiomac.2021.12.093 34973264
     [Google Scholar]
  7. KurniasihM. CahyatiT. DewiR.S. Carboxymethyl chitosan as an antifungal agent on gauze.Int. J. Biol. Macromol.201811916617110.1016/j.ijbiomac.2018.07.038 30009895
     [Google Scholar]
  8. MouryaV.K. InamdarN.N. TiwariA. Carboxymethyl chitosan and its applications.Adv. Mater. Lett.201011113310.5185/amlett.2010.3108
     [Google Scholar]
  9. JainA.K. SöderlindE. ViridénA. SchugB. AbrahamssonB. KnopkeC. TajarobiF. BlumeH. AnschützM. WelinderA. RichardsonS. NagelS. Abrahmsén-AlamiS. WeitschiesW. The influence of hydroxypropyl methylcellulose (HPMC) molecular weight, concentration and effect of food on in vivo erosion behavior of HPMC matrix tablets.J. Control. Release2014187505810.1016/j.jconrel.2014.04.058 24818771
     [Google Scholar]
  10. AltmanR. BoschB. BruneK. PatrignaniP. YoungC. Advances in NSAID development: Evolution of diclofenac products using pharmaceutical technology.Drugs201575885987710.1007/s40265‑015‑0392‑z 25963327
     [Google Scholar]
  11. PawanP. NitinK. PrakashP. Design and development of sustained release matrix tablet of diclofenac sodium using natural polymer. The Int.Res. J. Pharm.202441169176
     [Google Scholar]
  12. FarinhaI. FreitasF. Chemically modified chitin, chitosan, and chitinous polymers as biomaterials.Handbook of Chitin and Chitosan.Elsevier202010.1016/B978‑0‑12‑817966‑6.00002‑9
     [Google Scholar]
  13. ShanmugamS. Formulation and evaluation of sustained release matrix tablets of levosulpiride by using natural polymer.Asian J. Pharm. Clin. Res.201710528529210.22159/ajpcr.2017.v10i5.17475
     [Google Scholar]
  14. JayaswalS.R. Felix JoeV. ViswanathB.A. Formulation and evaluation of sustained release matrix tablets of glibenclamide.Int. J. Pharm. Technol.20146265726586
     [Google Scholar]
  15. Schlick-HasperE. BethkeJ. VoglerN. GoedeckeT. Flow properties of powdery or granular filling substances of dangerous goods packagings—Comparison of the measurement of the angle of repose and the determination of the Hausner ratio.Packag. Technol. Sci.2022351076578210.1002/pts.2678
     [Google Scholar]
  16. SahabUddinM. In-process and finished products quality control tests for pharmaceutical tablets according to pharmacopoeias.J. Chem. Pharm. Res.20157918018510.9734/BJPR/2016/22044
     [Google Scholar]
  17. BerthomieuC. HienerwadelR. Fourier transform infrared (FTIR) spectroscopy.Photosynth. Res.20091012-315717010.1007/s11120‑009‑9439‑x 19513810
     [Google Scholar]
  18. GhoshD. DastidarD.G. BairagiR. AbatS. ChatterjeeA. Effect of particle size on dissolution profile of ciprofloxacin hydrochloride from floating matrix tablet.Int. J. Pharm. Res.2018102110117
     [Google Scholar]
  19. YukselN. KanikA.E. BaykaraT. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods.Int. J. Pharm.20002091-2576710.1016/S0378‑5173(00)00554‑8 11084246
     [Google Scholar]
  20. RajB.V. Vigna mungo mucilage - A natural polymer in the design of matrix based SR tablet of aceclofenac.Int. J. Pharm. Sci. Rev. Res.201321125130
     [Google Scholar]
  21. AliN. AhmadS. KhanA. KhanS. BilalM. Ud DinS. AliN. IqbalH.M.N. KhanH. Selenide‐chitosan as high‐performance nanophotocatalyst for accelerated degradation of pollutants.Chem. Asian J.202015172660267310.1002/asia.202000597 32598537
     [Google Scholar]
  22. EarleR.R. AyalasomayajulaL.U. RajuA.N. KumariK.T. KumarP.R. Formulation and evaluation of diclofenac sodium oro dispersible tablets using different superdisintegrants by direct compression technique.De. Pharmacia. Lettre201688227238
     [Google Scholar]
  23. DigkasT. PorfireA. Van RenterghemJ. SamaroA. BorodiG. VervaetC. CrișanA.G. IurianS. De BeerT. TomutaI. Development of diclofenac sodium 3D printed cylindrical and tubular-shaped tablets through hot melt extrusion and fused deposition modelling techniques.Pharmaceuticals2023168106210.3390/ph16081062 37630976
     [Google Scholar]
  24. WadherJ. PreparationD.K. Preparation and evaluation of chitosan-eudragit L 100 polymer-based sustained release tablet of diclofenac sodium.Asian J. Pharm.202014110511010.22377/ajp.v14i1.3535
     [Google Scholar]
  25. SiepmannJ. PeppasN.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).Adv. Drug Deliv. Rev.2001482-313915710.1016/S0169‑409X(01)00112‑0 11369079
     [Google Scholar]
  26. AkpabioE.I. EffiongD.E. UwahT.O. OfoefuleS.I. Effect of granules size on the release kinetics of ibuprofen from its matrix tablet.OAlib20229211510.4236/oalib.1107920
     [Google Scholar]
/content/journals/dmbl/10.2174/0118723128351869250213102431
Loading
Development and Optimization of Sustained-Release Matrix Tablets of Diclofenac Sodium Using Carboxymethylated Chitosan Through Systematic Application of Design of Experiments
Drug Metab. Bioanal. Lett. 17, 121 (2024); https://doi.org/10.2174/0118723128351869250213102431
/content/journals/dmbl/10.2174/0118723128351869250213102431
/content/journals/dmbl/10.2174/0118723128351869250213102431
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): carboxymethylated chitosan; Diclofenac sodium; dissolution profile comparison; mixture design; optimization; sustained-release tablet

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test